share_log

神威药业发布中期业绩 净利润4.91亿元同比增长48.4%

Shenwei Pharmaceutical announced interim results, net profit of 491 million yuan, up 48.4% year-on-year

新浪港股 ·  Aug 30, 2023 00:40

Shenwei Pharmaceutical (02877) released interim results for 2023, with a turnover of 2.399 billion yuan (RMB, the same below), up 32.1% from the same period last year, another record high in medium-term sales performance; net profit of 491 million yuan, an increase of 48.4% over the same period last year; and basic profit per share of 65 cents. Proposed interim dividend of 11 cents per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment